The White House made nine new agreements with pharmaceutical manufacturers to bring prescription drug prices for Americans down to the lowest prices paid by other developed nations, it said on Monday.
The nine manufacturers include Teva Pharmaceuticals (TEVA), BridgeBio (BBIO), Alcon (ALC), BeOne Medicines (ONC), Astellas Pharma, CSL, Kyowa Kirin, Sun Pharma, and UCB, the White House said.
The drugs include treatments for hemophilia, Parkinson's disease, macular degeneration, glaucoma, liver disease, skin conditions, and various forms of cancers, the White House said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.